NF-κB inhibition by the cardiac-specific deletion of NEMO, a regulatory subunit of the IKK complex, augmented cardiac hypertrophy and cardiac dysfunction after pressure overload stimulation [27]. The gene discussed is IKBKG; the disease is cardiac hypertrophy.